131 related articles for article (PubMed ID: 34059727)
1. Analyzing the relationship between the cytokine profile of invasive breast carcinoma, its histopathological characteristics and metastasis to regional lymph nodes.
Autenshlyus A; Arkhipov S; Mikhaylova E; Marinkin I; Arkhipova V; Varaksin N; Vavilin V; Lyahovich V
Sci Rep; 2021 May; 11(1):11359. PubMed ID: 34059727
[TBL] [Abstract][Full Text] [Related]
2. [Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].
Autenshlyus AI; Studenikina AA; Mikhaylova YS; Proskura AV; Varaksin NA; Sidorov SV; Bogachuk AP; Lipkin VM; Lyakhovich VV
Biomed Khim; 2020 Nov; 66(6):485-493. PubMed ID: 33372907
[TBL] [Abstract][Full Text] [Related]
3. Effects of polyclonal activators on cell differentiation and cytokine production of cultured invasive breast carcinoma of no special type, their association with tumour histopathological parameters and lymph node metastasis.
Autenshlyus A; Arkhipov S; Mikhailova E; Marinkin I; Varaksin N; Vavilin V; Lyakhovich V
Int J Immunopathol Pharmacol; 2020; 34():2058738420950580. PubMed ID: 33100082
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Between Cytokine Production, CSF2RA, and IL1R2 Expression in Mammary Adenocarcinoma, Tumor Histopathological Parameters, and Lymph Node Metastasis.
Autenshlyus A; Arkhipov S; Mikhailova E; Marinkin I; Arkhipova V; Varaksin N
Technol Cancer Res Treat; 2019; 18():1533033819883626. PubMed ID: 31635541
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production in mammary adenocarcinoma and its microenvironmental cells in patients with or without metastases in regional lymph nodes.
Autenshlyus A; Arkhipov S; Mikhailova E; Marinkin I; Arkhipova V; Mogilnaya E; Varaksin N; Rukavishnikov M
Int J Immunopathol Pharmacol; 2017 Sep; 30(3):308-314. PubMed ID: 28745079
[TBL] [Abstract][Full Text] [Related]
6. VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these malignant tumors.
Autenshlyus A; Arkhipov S; Mikhailova E; Arkhipova V; Varaksin N
Int J Immunopathol Pharmacol; 2018; 32():2058738418787990. PubMed ID: 29985074
[TBL] [Abstract][Full Text] [Related]
7. Cytokines in various molecular subtypes of breast cancer.
Autenshlyus A; Davletova K; Varaksin N; Marinkin I; Lyakhovich V
Int J Immunopathol Pharmacol; 2021; 35():20587384211034089. PubMed ID: 34399595
[TBL] [Abstract][Full Text] [Related]
8. [Cytokine production by blood immune cells, tumor and its microenvironment, characteristic of extracellular matrix in patients with invasive ductal carcinoma of no special type].
Autenshlyus AI; Davletova KI; Studenikina AA; Mikhaylova ES; Varaksin NA; Zhurakovsky IP; Proskura AV; Sidorov SV; Lyakhovich VV
Biomed Khim; 2019 Aug; 65(5):424-431. PubMed ID: 31666416
[TBL] [Abstract][Full Text] [Related]
9. Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.
Autenshlyus AI; Arkhipov SA; Kunts TA; Marinkin IO; Mikhailova ES; Karpukhina XV; Varaksin NA
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):83-88. PubMed ID: 27903846
[TBL] [Abstract][Full Text] [Related]
10. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.
Mehdipour F; Razmkhah M; Faghih Z; Bagheri M; Talei AR; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):381-395. PubMed ID: 30850950
[TBL] [Abstract][Full Text] [Related]
11. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.
Ma Y; Ren Y; Dai ZJ; Wu CJ; Ji YH; Xu J
Adv Clin Exp Med; 2017; 26(3):421-426. PubMed ID: 28791816
[TBL] [Abstract][Full Text] [Related]
12. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes.
Olszewski WL; Pazdur J; Kubasiewicz E; Zaleska M; Cooke CJ; Miller NE
Arthritis Rheum; 2001 Mar; 44(3):541-9. PubMed ID: 11263768
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between supernatant cytokines and expression of markers of epitelial-mesenchymal transition of invasive breast carcinoma of non-specific lymphynosis type].
Autenshlyus AI; Studenikina AA; Arkhipov SA; Davletova KI; Zhurakovsky IP; Proskura AV; Varaksin NA; Lyakhovich VV
Biomed Khim; 2020 Jan; 66(1):83-88. PubMed ID: 32116230
[TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
Kuerer HM; Peoples GE; Sahin AA; Murray JL; Singletary SE; Castilleja A; Hunt KK; Gershenson DM; Ioannides CG
J Interferon Cytokine Res; 2002 May; 22(5):583-92. PubMed ID: 12060497
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases].
Autenshlyus AI; Studenikina AA; Bernado AV; Mikhailova ES; Proskura AV; Sidorov SV; Varaksin NA; Lyakhovich VV
Biomed Khim; 2019 Aug; 65(5):418-423. PubMed ID: 31666415
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen receptor negative breast cancers exhibit high cytokine content.
Chavey C; Bibeau F; Gourgou-Bourgade S; Burlinchon S; Boissière F; Laune D; Roques S; Lazennec G
Breast Cancer Res; 2007; 9(1):R15. PubMed ID: 17261184
[TBL] [Abstract][Full Text] [Related]
17. Cytokines as prognstic tool in breast carcinoma.
Lv M; Xiaoping X; Cai H; Li D; Wang J; Fu X; Yu F; Sun M; Lv Z
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2515-26. PubMed ID: 21622192
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
19. [Expression of FoxM1 and BCRP in invasive breast carcinoma of no special type and its prognosis significance].
Liu Y; Liu YP; Liu JY; Yang HC; Wang ZD
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):30-33. PubMed ID: 28072973
[No Abstract] [Full Text] [Related]
20. Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
Dehqanzada ZA; Storrer CE; Hueman MT; Foley RJ; Harris KA; Jama YH; Shriver CD; Ponniah S; Peoples GE
Oncol Rep; 2007 Mar; 17(3):687-94. PubMed ID: 17273752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
